Last checked at 21 Jun 2017 14:35
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Mrs V A Whyte | ||||
b) | Position/status | Company Secretary | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each "Ordinary Shares"
ISIN: GB0009252882
| ||||
b) | Nature of the transaction | The exercise of options over 4,820 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline 2001 Share Option Plan - UK Unapproved Trust. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
Aggregated volume Price | n/a (single transaction)
| ||||
e) | Date of the transaction | 2017-06-20 | ||||
f) | Place of the transaction
| n/a | ||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Mrs V A Whyte | ||||
b) | Position/status | Company Secretary | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each "Ordinary Shares"
ISIN: GB0009252882
| ||||
b) | Nature of the transaction | The sale of 4,820 Ordinary Shares following the exercise of options granted on 19 February 2008 under the GlaxoSmithKline 2001 Share Option Plan - UK Unapproved Trust. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
Aggregated volume Price | n/a (single transaction)
| ||||
e) | Date of the transaction | 2017-06-20 | ||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||